L. Musey et al., CYTOTOXIC-T-CELL RESPONSES, VIRAL LOAD, AND DISEASE PROGRESSION IN EARLY HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION, The New England journal of medicine, 337(18), 1997, pp. 1267-1274
Background Early in human immunodeficiency virus type 1 (HIV-1) infect
ion there is a decline in viral replication that has been attributed t
o host immunity, but the components of this response, particularly the
ability of cytotoxic T lymphocytes to control viral burden and influe
nce the outcome of disease, are poorly understood. Methods We prospect
ively studied 33 patients with primary HIV-1 infection for HIV-specifi
c activated cytotoxic T lymphocytes and memory cytotoxic T lymphocytes
and compared these lymphocyte responses with changes in viral load an
d clinical status over the subsequent 18 to 24 months. Results Soon af
ter infection, activated HIV-specific cytotoxic T lymphocytes, mediate
d primarily by CD8+ cells, were detected in 17 of 23 patients (74 perc
ent). Memory cytotoxic T lymphocytes were found in 6 of 6 patients tes
ted (100 percent) during the first three months of infection and in 17
of 21 patients (81 percent) tested during the first six months. The f
requencies of memory cytotoxic T lymphocytes varied markedly over time
, but overall they declined over the first 6 to 8 months and then stab
ilized over the next 12 to 18 months. The patients with higher frequen
cies of Env-specific memory cytotoxic T lymphocytes had a median level
of plasma HIV-1 RNA about one third that of the patients with lower f
requencies (median number of RNA copies per milliliter, 22,000 vs. 62,
000; P=0.006). Patients with low frequencies of Env-specific memory cy
totoxic T lymphocytes (or none) in early infection had a more rapid de
cline to less than 300 CD4+ cells per cubic millimeter (P=0.05). Concl
usions In early HIV-1 infection, the induction of memory cytotoxic T l
ymphocytes, particularly those specific for Env, helps control viral r
eplication and is associated with slower declines in CD4+ cell counts.
Host cytolytic effector responses appear to delay the progression of
HIV-1 disease. (C) 1997, Massachusetts Medical Society.